Metabolism of the 4-iodo derivative of tamoxifen by isolated rat hepatocytesMCCAGUE, R; PARR, I. B; HAYNES, B. P et al.Biochemical pharmacology. 1990, Vol 40, Num 10, pp 2277-2283, issn 0006-2952, 7 p.Article

Role of «lymphotoxin» in the local anti-tumour action associated with inflammation caused by delayed hypersensitivity responses or intralesional BCG. I: Variations in response of different syngeneic mouse tumours = Rôle des «lymphotoxines» dans l'action antitumorale LOCALE ASSOCIéE à L'inflammation causée par les réponses d'hypersensibilité retardée ou le BCG intralésionnel. I. Variations dans la réponse de différentes tumeurs syngéniques de sourisPARR, I. B; JACKSON, L. E; ALEXANDER, P et al.British journal of cancer. 1983, Vol 48, Num 3, pp 395-403, issn 0007-0920Article

Mapping the aspartic acid binding site of Escherichia coli asparagine synthetase B using substrate analogsPARR, I. B; BOEHLEIN, S. K; DRIBBEN, A. B et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 12, pp 2367-2378, issn 0022-2623Article

Metabolism of 4-hydroxyandrost-4-ene-3,17-dione by rat hepatocytesFOSTER, A. B; JARMAN, M; MANN, J et al.Journal of steroid biochemistry. 1986, Vol 24, Num 2, pp 607-617, issn 0022-4731Article

Metabolism of tamoxifen by isolated rat hepatocytes : identification of the glucuronide of 4-hydroxytamoxifenMCCAGUE, R; PARR, I. B; LECLERCQ, G et al.Biochemical pharmacology. 1990, Vol 39, Num 9, pp 1459-1465, issn 0006-2952, 7 p.Article

Inhibition of the formation of 4-hydroxyandrostenedione glucuronide by valproatePARR, I. B; ROWLANDS, M. G; HOUGHTON, J et al.Biochemical pharmacology. 1988, Vol 37, Num 23, pp 4581-4583, issn 0006-2952Article

Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicityROWLANDS, M. G; PARR, I. B; MCCAGUE, R et al.Biochemical pharmacology. 1990, Vol 40, Num 2, pp 283-289, issn 0006-2952, 7 p.Article

Metabolism of tamoxifen by isolated rat hepatocytes: identification of 1-[4-(2-hydroxyethoxy)phenyl]-1-(4-hydroxyphenyl)-2-phenyl-1-butene and the dependence of N-oxidation on oxygen availabilityPARR, I. B; MCCAGUE, R; LECLERCQ, G et al.Biochemical pharmacology. 1987, Vol 36, Num 9, pp 1513-1519, issn 0006-2952Article

3-Acetamido-5-O-acetyl-1,2-O-isopropylidene-D-ribofuranoseABBOUD, K. A; PARR, I. B; HORENSTEIN, B. A et al.Acta crystallographica. Section C, Crystal structure communications. 1997, Vol 53, pp 245-247, issn 0108-2701, 2Article

Rationally designed analogues of tamoxifen with improved calmodulin antagonismHARDCASTLE, I. R; ROWLANDS, M. G; HOUGHTON, J et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 2, pp 241-248, issn 0022-2623Article